SPX3,934.61-64.23 -1.61%
DIA336.03-4.00 -1.18%
IXIC11,016.30-223.64 -1.99%

--B. Riley Downgrades Cassava Sciences to Neutral From Buy, Notes Challenging Near-Term Catalyst Profile, Prolonged Litigation Mess; Maintains $44 PT

--B. Riley Downgrades Cassava Sciences to Neutral From Buy, Notes Challenging Near-Term Catalyst Profile, Prolonged Litigation Mess; Maintains $44 PT

MT Newswires · 11/16/2022 03:02

Please log in to view news